Nectar Lifesciences Limited – NSE:NECLIFE.NS
Nectar Lifesciences Limited stock price today
Nectar Lifesciences Limited stock price monthly change
Nectar Lifesciences Limited stock price quarterly change
Nectar Lifesciences Limited stock price yearly change
Nectar Lifesciences Limited key metrics
Market Cap | 9.18B |
Enterprise value | 11.78B |
P/E | -23.49 |
EV/Sales | 0.73 |
EV/EBITDA | 10.73 |
Price/Sales | 0.24 |
Price/Book | 0.36 |
PEG ratio | -0.17 |
EPS | 0.22 |
Revenue | 16.85B |
EBITDA | 1.64B |
Income | 49.94M |
Revenue Q/Q | 13.78% |
Revenue Y/Y | 10.62% |
Profit margin | -1% |
Oper. margin | 1.64% |
Gross margin | 24.43% |
EBIT margin | 1.64% |
EBITDA margin | 9.74% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeNectar Lifesciences Limited stock price history
Nectar Lifesciences Limited stock forecast
Nectar Lifesciences Limited financial statements
| Jun 2023 | 3.94B | 18.20M | 0.46% |
|---|---|---|---|
| Sep 2023 | 3.97B | 10.15M | 0.26% |
| Dec 2023 | 4.52B | 15.66M | 0.35% |
| Mar 2024 | 4.41B | 5.92M | 0.13% |
| Payout ratio | 0% |
|---|
| 2016 | 0.26% |
|---|---|
| 2017 | 0.34% |
| 2019 | 0.34% |
| 2020 | 0.62% |
| 2022 |
| Jun 2023 | 0 | 0 | |
|---|---|---|---|
| Sep 2023 | 21427271000 | 10.75B | 50.18% |
| Dec 2023 | 0 | 0 | |
| Mar 2024 | 21910563000 | 11.21B | 51.2% |
| Jun 2023 | 306.65M | 0 | 0 |
|---|---|---|---|
| Sep 2023 | 306.24M | 0 | 0 |
| Dec 2023 | 307.47M | 0 | 0 |
| Mar 2024 | 0 | 0 | 0 |
Nectar Lifesciences Limited alternative data
| Aug 2023 | 1,669 |
|---|---|
| Sep 2023 | 1,589 |
| Oct 2023 | 1,589 |
| Nov 2023 | 1,589 |
| Dec 2023 | 1,589 |
| Jan 2024 | 1,589 |
| Feb 2024 | 1,589 |
| Mar 2024 | 1,589 |
| Apr 2024 | 1,589 |
| May 2024 | 1,589 |
| Jun 2024 | 1,589 |
| Jul 2024 | 1,589 |
Nectar Lifesciences Limited other data
| Insider | Compensation |
|---|---|
Mr. Sanjiv Goyal (1960) Chairman & MD | $19,280,000 |
Dr. Dinesh Dua MBA (1955) Executive Director | $8,600,000 |
-
What's the price of Nectar Lifesciences Limited stock today?
One share of Nectar Lifesciences Limited stock can currently be purchased for approximately $28.45.
-
When is Nectar Lifesciences Limited's next earnings date?
Unfortunately, Nectar Lifesciences Limited's (NECLIFE.NS) next earnings date is currently unknown.
-
Does Nectar Lifesciences Limited pay dividends?
No, Nectar Lifesciences Limited does not pay dividends.
-
How much money does Nectar Lifesciences Limited make?
Nectar Lifesciences Limited has a market capitalization of 9.18B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 0.91% to 16.84B US dollars.
-
What is Nectar Lifesciences Limited's stock symbol?
Nectar Lifesciences Limited is traded on the NSE under the ticker symbol "NECLIFE.NS".
-
What is Nectar Lifesciences Limited's primary industry?
Company operates in the Healthcare sector and Drug Manufacturers - Specialty & Generic industry.
-
How do i buy shares of Nectar Lifesciences Limited?
Shares of Nectar Lifesciences Limited can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Nectar Lifesciences Limited's key executives?
Nectar Lifesciences Limited's management team includes the following people:
- Mr. Sanjiv Goyal Chairman & MD(age: 65, pay: $19,280,000)
- Dr. Dinesh Dua MBA Executive Director(age: 70, pay: $8,600,000)
-
How many employees does Nectar Lifesciences Limited have?
As Jul 2024, Nectar Lifesciences Limited employs 1,589 workers.
-
When Nectar Lifesciences Limited went public?
Nectar Lifesciences Limited is publicly traded company for more then 20 years since IPO on 18 Jul 2005.
-
What is Nectar Lifesciences Limited's official website?
The official website for Nectar Lifesciences Limited is neclife.com.
-
How can i contact Nectar Lifesciences Limited?
Nectar Lifesciences Limited can be reached via phone at +91 172 304 7777.
Nectar Lifesciences Limited company profile:
Nectar Lifesciences Limited
neclife.comNSE
1,686
Drug Manufacturers - Specialty & Generic
Healthcare
Nectar Lifesciences Limited manufactures and sells pharmaceutical products in India and internationally. The company offers contract research and manufacturing services, including process development and optimization, process scale up and validation, preparation and international submission of drug master files and certificates of suitability, multi kilo pilot plant production, bulk production, and chiral resolution; and chemical and analytical development, as well as analytical, manufacturing, and engineering consulting services. Its active pharmaceutical ingredients and intermediates comprise cefixime trihydrate, cefuroxime axetil, cefpodoxime proxetil, cefdinir, ceftriaxone sodium, cefotaxime sodium, cefuroxime sodium, ceftazidime, cefepime HCl, cephalothin, cefazolin sodium, cefprozil, cefoperzone sodium, cefpirome sulphate, and cefoxitin sodium. The company also offers contract manufacturing for finished dosage forms, such as tablets, capsules, dry powder oral suspensions, and granules and injectable for cephalosporins. In addition, it provides a range of diagnostics products; empty hard gelatin capsules; and menthol products. Nectar Lifesciences Limited was incorporated in 1995 and is headquartered in Chandigarh, India.
Chandigarh, 160009
:
ISIN: INE023H01027
CUSIP: Y6238X101
